These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15448098)

  • 1. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products.
    Marx N; Walcher D; Ivanova N; Rautzenberg K; Jung A; Friedl R; Hombach V; de Caterina R; Basta G; Wautier MP; Wautiers JL
    Diabetes; 2004 Oct; 53(10):2662-8. PubMed ID: 15448098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells.
    Tanaka N; Yonekura H; Yamagishi S; Fujimori H; Yamamoto Y; Yamamoto H
    J Biol Chem; 2000 Aug; 275(33):25781-90. PubMed ID: 10829018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of angiotensin II receptors reduces the expression of receptors for advanced glycation end products in human endothelial cells.
    Fujita M; Okuda H; Tsukamoto O; Asano Y; Hirata YL; Kim J; Miyatsuka T; Takashima S; Minamino T; Tomoike H; Kitakaze M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):e138-42. PubMed ID: 16888237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.
    Bierhaus A; Illmer T; Kasper M; Luther T; Quehenberger P; Tritschler H; Wahl P; Ziegler R; Müller M; Nawroth PP
    Circulation; 1997 Oct; 96(7):2262-71. PubMed ID: 9337199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
    Morcos M; Schlotterer A; Sayed AA; Kukudov G; Oikomonou D; Ibrahim Y; Pfisterer F; Schneider J; Bozorgmehr F; Rudofsky G; Schwenger V; Kientsch-Engels R; Hamann A; Zeier M; Dugi K; Yard B; Humpert PM; van der Woude F; Nawroth PP; Bierhaus A
    Horm Metab Res; 2008 Nov; 40(11):752-9. PubMed ID: 18711692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
    Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
    J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pioglitazone on insulin resistance in fructose-drinking rats correlates with AGEs/RAGE inhibition and block of NADPH oxidase and NF kappa B activation.
    Liu X; Luo D; Zheng M; Hao Y; Hou L; Zhang S
    Eur J Pharmacol; 2010 Mar; 629(1-3):153-8. PubMed ID: 20004657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
    Schmidt AM; Hori O; Chen JX; Li JF; Crandall J; Zhang J; Cao R; Yan SD; Brett J; Stern D
    J Clin Invest; 1995 Sep; 96(3):1395-403. PubMed ID: 7544803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
    Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells.
    Kurebayashi S; Xu X; Ishii S; Shiraishi M; Kouhara H; Kasayama S
    Atherosclerosis; 2005 Sep; 182(1):71-7. PubMed ID: 16115476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
    Gao H; Li H; Li W; Shen X; Di B
    Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.
    Chen F; Ghosh A; Hu M; Long Y; Sun H; Kong L; Hong H; Tang S
    Neurotox Res; 2018 Feb; 33(2):284-299. PubMed ID: 28871412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone inhibits advanced glycation end product-induced TNF-α and MMP-13 expression via the antagonism of NF-κB activation in chondrocytes.
    Chen C; Ma C; Zhang Y; Zeng Y; Li Y; Wang W
    Pharmacology; 2014; 94(5-6):265-72. PubMed ID: 25471680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
    Yamagishi S; Takeuchi M
    Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
    Bierhaus A; Schiekofer S; Schwaninger M; Andrassy M; Humpert PM; Chen J; Hong M; Luther T; Henle T; Klöting I; Morcos M; Hofmann M; Tritschler H; Weigle B; Kasper M; Smith M; Perry G; Schmidt AM; Stern DM; Häring HU; Schleicher E; Nawroth PP
    Diabetes; 2001 Dec; 50(12):2792-808. PubMed ID: 11723063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of advanced glycation end-products on renal tubular cell inflammation.
    Tang SC; Chan LY; Leung JC; Cheng AS; Lin M; Lan HY; Lai KN
    Nephrology (Carlton); 2011 May; 16(4):417-25. PubMed ID: 21143336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
    Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
    Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15.
    Puddu A; Sanguineti R; Durante A; Viviani GL
    Regul Pept; 2012 Aug; 177(1-3):79-84. PubMed ID: 22587907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes.
    Figarola JL; Shanmugam N; Natarajan R; Rahbar S
    Diabetes; 2007 Mar; 56(3):647-55. PubMed ID: 17327432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.